RJ Hamster
Stansberry Research
 Dear Reader,Today could have a big impact on the research you’re already following.Here’s why…25-year market veteran Jonathan Rose, the head trader at our corporate affiliate InvestorPlace, is going to reveal a small “tweak” you can make to your investing approach that could amplify the profit potential of any stock by 500% or more.This may sound too good to be true, but consider this…Over the past few months, Jonathan has already handed folks big winning recommendations on regular stocks, including:951% in 31 days on lithium miner Albemarle…1,200% in only 13 days from two trades on the rare earths play MP Materials…And 462% in 13 days on AI stock C3 ai.To prove you can achieve similar results, three top analysts in our industry all provided their No. 1 stock recommendation for free, which you can access here.Then, at 1 p.m. Eastern time today, Jonathan will reveal the secret to amplifying their profit potential by 500% or more.You can get these three stock recommendations right here.But a fair warning…This is your last chance to claim them before Jonathan goes live at 1 p.m. Eastern time today.Click here to learn more… then make sure to tune in this afternoon.Regards,Matt WeinschenkDirector of Research, Stansberry ResearchPublished by Stansberry Research.You have received this e-mail as part of your optin to Stansberry Research. If you no longer wish to receive special offers from Stansberry Research, click here.You’re receiving this e-mail at pahovis@aol.com. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com . This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice.© 2025 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 stansberryresearch.com. |
